Clinical Predictors of Polyautoimmunity in Autoimmune Liver Diseases: Insights into Disease Complexity
Journal of Clinical Medicine · 20.07.2025 · 14 (14) · 5143
DOI: 10.3390/jcm14145143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.07.2025. Verfasst von Özge Güçbey Türker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ankara City Hospital, University of Health Sciences, Ankara 06800, Turkey. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Autoimmune liver diseases (ALDs) are a diverse group of chronic inflammatory disorders. Individuals with a history of one autoimmune disease (AD) are at a substantially increased risk of developing additional autoimmune conditions. Polyautoimmunity has increasingly been recognized as a factor associated with a more complex disease course and poorer long-term outcomes.
Methods
This retrospective, cross-sectional observational study reviewed medical records of patients diagnosed with ALDs who had been admitted to the gastroenterology clinic.
Results
A total of 457 patients with ALDs were included. Polyautoimmunity was present in 194 patients (42.5%), and multiple autoimmune syndrome (MAS) was diagnosed in 26 of these patients (5.7%). Serological comparisons revealed that antinuclear antibody (ANA) positivity was significantly more common in the polyautoimmunity group. Only 22.2% of the patients with polyautoimmunity were ANA-negative, compared with 52.9% in those without. An ROC curve analysis was conducted to assess the predictive value of clinical and laboratory variables for polyautoimmunity. Among all the tested parameters, ANA positivity (>+2) had the strongest predictive value (AUC: 0.724). A disease duration longer than 6.5 years followed, with a moderate discriminative capacity (AUC: 0.677). Additionally, lower albumin levels (29.5 mm/h) were significantly associated with polyautoimmunity.
Conclusions
In our cohort, 42.5% of patients had at least one additional autoimmune disorder, highlighting the need for a systemic and comprehensive approach to patient care. Simple and accessible markers—such as ANA titers, disease duration, albumin levels, and ESRs—may help to identify patients at greater risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Ankara City Hospital, University of Health Sciences, Ankara 06800, Turkey.
- Department of Gastroenterology, Ankara City Hospital, University of Health Sciences, Ankara 06800, Turkey.
- Department of Gastroenterology, Faculty of Medicine, Gazi University, Ankara 06560, Turkey.
- Department of Gastroenterology, Faculty of Medicine, Ankara University, Ankara 06230, Turkey.
ORCID-Profile: Özge Güçbey Türker, Gülden Bilican, Ali Atay
Zitieren
APA
Güçbey Türker, Ö., Kalkan, Ç., Bilican, G., Asfuroğlu Kalkan, E., Atay, A., Ateş, İ., & Soykan, İ. (2025). Clinical Predictors of Polyautoimmunity in Autoimmune Liver Diseases: Insights into Disease Complexity. Journal of Clinical Medicine, 14(14), 5143. https://doi.org/10.3390/jcm14145143
Vancouver
Güçbey Türker Ö, Kalkan Ç, Bilican G, Asfuroğlu Kalkan E, Atay A, Ateş İ, et al. Clinical Predictors of Polyautoimmunity in Autoimmune Liver Diseases: Insights into Disease Complexity. Journal of Clinical Medicine. 2025;14(14):5143. doi:10.3390/jcm14145143
BibTeX
@article{GbeyTrker2025,
author = {Güçbey Türker, Özge and Kalkan, Çağdaş and Bilican, Gülden and Asfuroğlu Kalkan, Emra and Atay, Ali and Ateş, İhsan and Soykan, İrfan},
title = {Clinical Predictors of Polyautoimmunity in Autoimmune Liver Diseases: Insights into Disease Complexity},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {14},
pages = {5143},
doi = {10.3390/jcm14145143}
}
EUVIMED